NeoRx to Present at Invest Northwest Conference
April 20 2005 - 8:01AM
PR Newswire (US)
NeoRx to Present at Invest Northwest Conference SEATTLE, April 20
/PRNewswire-FirstCall/ -- NeoRx Corporation (NASDAQ:NERX) today
announced that Chairman and Chief Executive Officer Jerry McMahon,
Ph.D. will present at the Invest Northwest 2005 CEO & Investor
Conference taking place April 26-27, 2005 at the Bell Harbor
International Convention Center in Seattle, Washington. McMahon
will present Tuesday, April 26 at 2:40 p.m. Pacific Time. A live
audio webcast will be available from the NeoRx Web site
http://www.neorx.com/ under the "Investor Information" section. A
replay of the presentation will be available for 10 days. About
NeoRx NeoRx is a cancer therapeutics development company. The
Company's product pipeline includes STR, a radiotherapeutic
targeting bone, currently in a pivotal Phase III clinical trial for
patients with multiple myeloma, and NX 473, a next-generation
platinum therapy that the Company plans to evaluate in the
treatment of patients with advanced lung and colorectal cancers.
For more information, visit http://www.neorx.com/. This release
contains forward-looking statements relating to the development of
the Company's products and future operating results that are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those projected. The words
"believe," "expect," "intend", "anticipate," variations of such
words, and similar expressions identify forward-looking statements,
but their absence does not mean that the statement is not
forward-looking. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties and
assumptions that are difficult to predict. Factors that could
affect the Company's actual results include the availability of
financing sources for the development of NeoRx's product
candidates, the progress and costs of clinical trials and the
timing of regulatory approvals, the ability to successfully develop
and commercialize products and the other risks and uncertainties
described in NeoRx's current and periodic reports filed with the
Securities and Exchange Commission, including NeoRx's Annual Report
on Form 10-K for the year ended December 31, 2004. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this release. The
Company undertakes no obligation to update any forward-looking
statement to reflect new information, events or circumstances after
the date of this release or to reflect the occurrence of
unanticipated events. NOTE: NeoRx and STR are trademarks or
registered trademarks of NeoRx Corporation in the United States
and/or foreign countries. DATASOURCE: NeoRx Corporation CONTACT:
Julie Rathbun of NeoRx Corporation, +1-206-286-2517, or Web site:
http://www.neorx.com/
Copyright
Neorx (NASDAQ:NERX)
Historical Stock Chart
From Oct 2024 to Oct 2024
Neorx (NASDAQ:NERX)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Neorx (MM) (NASDAQ): 0 recent articles
More Neorx (MM) News Articles